Kezza2 Posted February 20, 2019 Share Posted February 20, 2019 Just to alert fellow members, Amgen are gearing up to begin first phase human trials on their new immunotherapy drug, AMG 160, whit trials to begin in Sydney and Melbourne. This new drug utilises PSMA to direct the immune system to the cancer cells. You can find more information on the Amgen Clinical Trials website. Link to comment Share on other sites More sharing options...
kezza Posted March 3, 2019 Share Posted March 3, 2019 Hi Kezza2, I'm interested to find out more? Is Amgen similar to Lutetium- 177. I'm speaking to my oncologist tomorrow and there is not much left for me to try. In this order I have already been on Androcure, Zytiga, Docetaxel, Cabazitaxel, Xtandi now my PSA is rising again. He has suggested perhaps trying Carboplatin. or paying $10,000 per treatment for Lutetium as he says I may not be eligible for inclusion in the trial. thanks for any suggestions. Kezza Link to comment Share on other sites More sharing options...
Kezza2 Posted March 3, 2019 Author Share Posted March 3, 2019 Hi Kezza, From what I understand, AMG 160 is a PSMA directed immunotherapy treatment. I am sure your oncologist will be aware of the trial, and would be the first person to talk to about it and possibly getting on the trial. The details of eligibility etc are on the clinical trials website at https://clinicaltrials.gov/ct2/show/NCT03792841 Details of the pre-clinical trials are at : https://meetinglibrary.asco.org/record/169946/abstract Hang in there comrade. Link to comment Share on other sites More sharing options...
kezza Posted March 4, 2019 Share Posted March 4, 2019 Hi Kezza 2, Thanks for your update. Yes I spoke to Dr this morning and that trial is in very early days and not for me. I'm hoping to get on the LuPin Trial. I'll keep you posted. Thanks Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.